influenza
flu
highli
contagi
respiratori
ill
affect
year
million
peopl
three
genera
influenza
virus
b
c
influenza
influenza
b
virus
pose
continu
threat
public
health
current
influenza
virus
subtyp
influenza
b
virus
cocircul
vari
predomin
human
popul
respons
season
epidem
may
result
million
case
sever
respiratori
ill
annual
death
worldwid
natur
reservoir
influenza
virus
wild
aquat
bird
transmit
wide
rang
mammalian
avian
host
includ
human
pig
poultri
emerg
new
influenza
viru
littl
immun
human
popul
may
provok
influenza
pandem
devast
pandem
spanish
flu
claim
c
million
death
worldwid
addit
three
influenza
pandem
occur
centuri
asian
flu
hongkong
flu
recent
pandem
contrast
influenza
b
virus
predominantli
found
human
known
anim
reservoir
new
viru
variant
emerg
human
influenza
virus
spread
via
aerosol
respiratori
droplet
due
sneez
cough
may
also
spread
contact
infect
respiratori
epithelium
upper
lower
airway
influenza
acut
respiratori
ill
rapid
onset
symptom
fever
headach
gener
malais
myalgia
may
last
day
complic
may
due
bronchiti
viral
pneumonia
myocard
moreov
viralbacteri
pneumonia
secondari
bacteri
pneumonia
due
concomit
subsequ
infect
bacteria
respect
contribut
significantli
morbid
mortal
influenza
infect
commonli
isol
bacteria
streptococcu
pneumonia
pneumococcu
staphylococcu
aureu
haemophilu
influenza
patholog
studi
autopsi
specimen
analys
medic
report
reveal
major
death
influenza
pandem
occur
concurr
bacteri
pneumonia
predominantli
h
influenza
mcculler
moren
et
al
estim
sever
fatal
case
pandem
c
influenzaassoci
pneumonia
pandem
like
result
pneumonia
due
coinfect
aureu
pneumococcu
season
influenza
epidem
estim
hospit
influenzaassoci
death
due
secondari
bacteri
pneumonia
peltola
et
al
mcculler
influenza
virus
belong
famili
orthomyxovirida
envelop
virus
pleomorph
morpholog
rang
spheric
filament
particl
diamet
nm
genom
consist
eight
segment
singlestrand
negativesens
rna
associ
polymeras
protein
pa
multipl
copi
nucleoprotein
np
form
viral
ribonucleoprotein
complex
vrnp
togeth
encod
protein
jagger
et
al
muramoto
et
al
fig
viral
envelop
made
lipid
bilay
deriv
host
cellular
plasma
membran
contain
two
major
spike
glycoprotein
hemagglutinin
ha
neuraminidas
na
proton
channel
protein
inner
side
envelop
line
matrix
protein
base
antigen
criteria
influenza
virus
classifi
ha
na
subtyp
date
tong
et
al
subtyp
circul
wild
aquat
bird
sporad
transmit
speci
includ
human
influenza
viru
replic
initi
ha
bind
nacetylneuramin
acidcontain
cell
surfac
receptor
result
receptormedi
endocytosi
subsequ
fusion
viral
envelop
endosom
membran
releas
vrnp
cytoplasm
fig
membran
fusion
requir
proteolyt
cleavag
ha
induc
acid
ph
endosom
vrnp
import
nucleu
transcript
replic
genom
catalys
viral
rnadepend
rna
polymeras
splice
viral
mrna
translat
protein
perform
cellular
machineri
influenza
viru
infect
caus
shutoff
host
protein
synthesi
therebi
enhanc
translat
viral
mrna
later
stage
viral
infect
newli
synthes
vrnp
viral
protein
transport
apic
membran
polar
epitheli
cell
assembl
bud
new
progeni
virion
take
place
na
cleav
nacetylneuramin
acid
carbohydr
moieti
facilit
releas
progeni
viru
host
cell
prevent
virion
clump
togeth
ha
major
surfac
glycoprotein
influenza
virus
mediat
receptor
bind
membran
fusion
main
target
neutral
antibodi
ha
type
transmembran
protein
integr
viral
envelop
homotrim
ha
synthes
precursor
protein
kda
transport
along
constitut
secretori
pathway
plasma
membran
fig
transport
ha
becom
nglycosyl
palmitoyl
cleav
subunit
kda
kda
fig
b
cleavag
take
place
either
transgolgi
network
tgn
cell
surfac
discuss
aminotermin
cleavag
fragment
contain
receptorbind
site
remain
link
disulphid
bond
carboxytermin
fragment
membraneanchor
respons
fusion
fig
cleav
specif
arginin
residu
r
expos
fusion
peptid
consist
hydrophob
amino
acid
nterminu
cleavag
prerequisit
conform
chang
low
ph
endosom
trigger
membran
fusion
essenti
infect
spread
influenza
virus
cleavag
site
locat
promin
loop
protrud
surfac
fig
amino
acid
sequenc
well
structur
suscept
cleavag
site
critic
cleavag
ha
differ
proteas
klenk
rott
klenk
garten
steinhauer
garten
klenk
avian
influenza
virus
respons
recurr
outbreak
poultri
farm
worldwid
lead
seriou
econom
loss
poultri
industri
avian
virus
differ
pathogen
classifi
either
lowor
highpathogen
avian
influenza
virus
lpaiv
hpaiv
respect
lpaiv
replic
primarili
intestin
also
respiratori
tract
bird
caus
mild
asymptomat
infect
spread
via
faecalor
rout
contrast
hpaiv
caus
system
infect
poultri
mortal
rate
known
fowl
plagu
avian
influenza
hpaiv
restrict
subtyp
natur
set
virus
highli
pathogen
alreadi
earli
studi
natur
avian
influenza
viru
isol
indic
cleavag
site
sequenc
connect
key
determin
pathogen
organ
tropism
virus
lpaiv
possess
singl
arginin
rare
singl
lysin
cleavag
site
wherea
ha
hpaiv
contain
multibas
motif
consensu
sequenc
rxrkr
cleavag
crucial
viru
infect
lpaiv
found
requir
addit
exogen
trypsin
tissu
cultur
proteolyt
activ
multicycl
replic
vitro
wherea
hpaiv
shown
activ
endogen
proteas
klenk
rott
klenk
garten
ha
multibas
cleavag
site
cleav
ubiquit
subtilisinlik
endoproteas
furin
proprotein
convertas
support
system
infect
ober
et
al
horimoto
et
al
feldmann
et
al
furin
type
transmembran
proteas
predominantli
local
tgn
also
transport
constitut
secretori
pathway
plasma
membran
shed
recycl
target
back
tgn
afer
et
al
furin
cleav
larg
number
cellular
protein
precursor
prohormon
growth
factor
cterminu
consensu
sequenc
rxrkr
biolog
activ
form
moreov
furin
support
proteolyt
activ
larg
number
viral
glycoprotein
eg
measl
viru
respiratori
syncyti
viru
yellow
fever
viru
ebola
nuclear
export
protein
nep
fig
scheme
influenza
viru
particl
virion
contain
lipid
envelop
deriv
cellular
plasma
membran
two
glycoprotein
hemagglutinin
ha
neuraminidas
na
ion
channel
protein
embed
envelop
inner
side
line
matrix
protein
genom
consist
eight
segment
singlestrand
negativesens
rna
associ
nucleoprotein
np
polymeras
subunit
pa
form
viral
ribonucleoprotein
complex
vrnp
nuclear
export
protein
nep
also
present
virion
nonstructur
protein
pax
present
infect
cell
b
influenza
viru
replic
proteolyt
activ
cellular
proteas
human
airway
epitheli
cell
infect
initi
ha
bind
nacetyl
neuramin
acidcontain
cell
surfac
receptor
upon
receptormedi
endocytosi
ha
mediat
fusion
viral
endosom
membran
low
ph
releas
vrnp
cytoplasm
uncoat
vrnp
import
nucleu
transcript
replic
viral
genom
occur
translat
viral
mrna
perform
cellular
machineri
ha
na
synthes
endoplasm
reticulum
er
transport
along
constitut
secretori
pathway
plasma
membran
intern
viral
protein
synthes
free
ribosom
protein
compon
vrnp
import
nucleu
assembl
new
vrnp
occur
final
vrnp
export
nucleu
transport
plasma
membran
selfassembl
viral
protein
lead
bud
new
virion
na
cleav
nacetyl
neuramin
acid
carbohydr
moieti
facilit
releas
progeni
virion
proteolyt
activ
ha
take
place
differ
compart
differ
time
point
viral
replic
indic
scissor
open
scissor
activ
proteas
close
scissor
enzymat
inact
proteas
truncat
scissor
solubl
proteas
ha
multibas
cleavag
site
cleav
furin
tgn
ha
contain
monobas
cleavag
site
cleav
tgn
hat
plasma
membran
either
assembl
bud
progeni
viru
attach
entri
cell
viru
bacteri
toxin
eg
anthrax
toxin
diphtheria
toxin
basic
motif
klenk
garten
thoma
thu
furin
play
import
role
numer
physiolog
well
pathogen
process
cleavag
ha
furin
take
place
tgn
fig
result
releas
infecti
progeni
viru
contain
cleav
ha
cell
support
spread
infect
contrast
lpaiv
possess
monobas
cleavag
site
proteolyt
activ
trypsin
vitro
klenk
et
al
relev
trypsinlik
proteas
present
restrict
number
tissu
respiratori
intestin
tract
limit
spread
infect
tissu
proteas
homolog
blood
clot
factor
xa
identifi
haactiv
proteas
chorioallanto
membran
embryon
chicken
egg
gotoh
et
al
number
trypsinlik
proteas
plasmin
lazarowitz
choppin
tryptas
clara
kido
et
al
found
activ
ha
monobas
cleavag
site
vitro
ident
relev
proteas
respiratori
intestin
tract
avian
speci
howev
remain
investig
human
proteas
hat
present
human
airway
epithelium
identifi
proteas
activ
ha
monobas
cleavag
ottcher
et
al
chicken
proteas
homolog
human
demonstr
activ
ha
monobas
cleavag
site
vitro
suggest
might
respons
cleavag
ha
also
avian
host
bertram
et
al
hpaiv
emerg
lpaiv
extens
cleavag
site
loop
due
insert
mostli
basic
amino
acid
fig
interestingli
acquisit
multibas
cleavag
site
activ
furin
seem
restrict
subtyp
observ
subtyp
natur
set
klenk
garten
garten
klenk
analysi
cleavag
site
differ
hpaiv
demonstr
extens
cleavag
site
occur
differ
mechan
polymeras
slippag
purinerich
arginin
lysin
codon
recombin
viral
gene
segment
np
gene
ribosom
rna
still
unknown
mechan
review
detail
studi
garten
klenk
alreadi
earli
studi
demonstr
substitut
multibas
cleavag
site
hpaiv
monobas
motif
result
lowpathogen
viru
howev
insert
multibas
cleavag
motif
ha
monobas
cleavag
site
automat
confer
high
pathogen
viru
demonstr
emerg
hpaiv
multifactori
process
stech
et
al
schrauwen
et
al
recent
studi
veit
et
al
introduc
multibas
cleavag
site
ha
sever
influenza
viru
subtyp
gener
reassort
virus
genet
background
highli
pathogen
viru
interestingli
reassort
multibas
cleavag
site
caus
lethal
infect
chicken
subtyp
observ
demonstr
multibas
ha
cleavag
site
confer
high
pathogen
subtyp
suitabl
genet
background
therefor
restrict
natur
hpaiv
isol
subtyp
seem
due
uniqu
abil
acquir
multibas
cleavag
site
natur
set
howev
underli
mechan
yet
understood
avian
mammalian
influenza
virus
human
influenza
virus
possess
monobas
cleavag
site
requir
activ
trypsinlik
proteas
season
pandem
influenza
virus
belong
subtyp
influenza
b
viru
respect
activ
ctermin
ha
cleavag
site
motif
iqsr
iesr
kqtr
subtyp
respect
fig
lker
influenza
b
virus
number
trypsinlik
proteas
isol
rat
swine
lung
tryptas
clara
miniplasmin
tryptas
shown
support
proteolyt
activ
multicycl
replic
human
influenza
virus
vitro
kido
et
al
kido
et
al
murakami
et
al
sato
et
al
genet
ident
unknown
proteas
still
remain
unclear
whether
play
role
vivo
infect
appropri
proteas
cleav
ha
human
airway
epithelium
unknown
recent
activ
ha
monobas
cleavag
site
plasmin
tryptas
clara
factor
xalik
proteas
embryon
chicken
egg
occur
outsid
cell
releas
newli
synthes
virion
probabl
alreadi
assembl
bud
ha
present
plasma
membran
accord
classic
dogma
activ
ha
monobas
cleavag
site
ha
cleavag
solubl
proteas
outsid
cell
studi
zhirnov
et
al
howev
demonstr
cleavag
ha
human
airway
epitheli
cell
occur
cellassoci
proteas
furthermor
activ
influenza
virus
human
intestin
cell
shown
take
place
intracellularli
zhirnov
et
al
relev
proteas
remain
unknown
studi
indic
cleavag
ha
human
proteas
may
perform
membranebound
proteas
search
human
haactiv
proteas
number
proteas
possess
trypsinlik
activ
clone
human
primari
tracheobronchi
epitheli
htbe
cell
ottcher
et
al
among
coupl
candid
two
proteas
hat
human
airway
trypsinlik
proteas
also
design
transmembran
proteas
serin
member
also
design
epitheliasin
demonstr
cleav
influenza
viru
ha
monobas
cleavag
site
support
multicycl
viru
replic
vitro
ottcher
et
al
later
proteas
shown
activ
ha
monobas
site
vitro
chaipan
et
al
contrast
trypsinlik
proteas
prostasin
hepsin
abl
activ
ha
upon
coexpress
mammalian
cell
bertram
et
al
auser
et
al
emphas
certain
trypsinlik
proteas
present
airway
support
proteolyt
activ
influenza
virus
hat
belong
famili
type
ii
transmembran
serin
proteas
ttsp
contain
ntermin
transmembran
domain
highli
variabl
stem
region
catalyt
domain
chymotrypsin
type
fig
promin
member
ttsp
digest
enzym
enteropeptidas
origin
isol
solubl
proteas
later
shown
catalyt
domain
membranebound
proteas
szabo
bugg
ttsp
synthes
singlechain
zymogen
activ
cleavag
ctermin
highli
conserv
arginin
lysin
residu
matur
form
fig
catalyt
domain
predict
remain
link
membraneanchor
domain
disulphid
bond
releas
solubl
proteas
physiolog
role
hat
still
unknown
interestingli
mice
defici
hat
respect
shown
lack
discern
phenotyp
kim
et
al
sale
et
al
hat
origin
isol
patient
chronic
airway
diseas
among
function
demonstr
cleav
fibrinogen
activ
proteaseactiv
receptor
increas
mucu
gene
express
stimul
bronchial
fibroblast
prolifer
airway
epitheli
cell
vitro
yoshinaga
et
al
chokki
et
al
matsushima
et
al
hat
express
promin
trachea
bronchi
also
detect
gastrointestin
tract
skin
brain
tabl
airway
epithelium
hat
shown
express
ciliat
cell
submucos
gland
mast
cell
takahashi
et
al
wide
express
epitheli
cell
respiratori
gastrointestin
urogenit
tract
high
express
level
prostat
colon
szabo
bugg
moreov
immunohistochem
studi
reveal
express
cardiac
myocyt
suggest
might
contribut
influenzaassoci
myocard
bertram
et
al
associ
prostat
carcinogenesi
two
differ
way
proteas
shown
overexpress
prostat
cancer
tissu
moreov
fusion
androgenregul
promot
differ
et
e
transcript
factor
gene
result
overexpress
respect
transcript
factor
seen
nearli
patient
establish
prognost
marker
prostat
carcinogenesi
tomlin
et
al
role
airway
remain
investig
express
studi
xenopu
oocyt
suggest
involv
regul
airway
surfac
liquid
asl
volum
proteolyt
cleavag
epitheli
sodium
channel
enac
donaldson
et
al
ttsp
predict
situat
plasma
membran
extracellular
catalyt
domain
addit
solubl
form
hat
describ
hat
origin
purifi
activ
solubl
proteas
sputum
patient
chronic
bronchiti
bronchial
asthma
yoshinaga
et
al
shown
releas
prostat
prostat
cancer
cell
afar
et
al
subcellular
local
enzymat
activ
hat
airway
epitheli
cell
investig
detail
far
howev
studi
madindarbi
canin
kidney
mdck
cell
doxycyclineinduc
express
either
proteas
prove
suitabl
model
system
ottcher
et
al
initi
studi
inhibit
influenza
viru
activ
mdckhat
cell
use
natur
synthet
proteas
inhibitor
demonstr
proteolyt
activ
ha
hat
effici
inhibit
exogen
proteas
inhibitor
ottcher
et
al
auser
et
al
sielaff
et
al
contrast
inhibit
viru
activ
requir
higher
inhibitor
concentr
interestingli
modif
proteas
inhibitor
attach
fatti
acid
improv
cellular
uptak
allow
effici
inhibit
ha
cleavag
mdck
cell
data
indic
cleavag
take
place
within
cell
inhibit
requir
cellular
uptak
inhibitor
wherea
cleavag
ha
hat
occur
plasma
membran
therefor
easi
access
exogen
inhibitor
fig
hat
shown
express
cell
surfac
mdck
cell
zymogen
matur
form
auser
et
al
incub
hator
cell
fluorogen
peptid
measur
proteas
activ
cell
surfac
reveal
hat
present
enzymat
activ
enzym
cell
surfac
show
poor
proteas
activ
fig
reason
lack
activ
cell
surfac
unknown
might
relat
presenc
proteas
inhibitor
miss
cofactor
lower
amount
cell
surfac
compar
hat
immunofluoresc
microscopi
transient
hatexpress
cell
demonstr
hat
express
cell
surfac
howev
accumul
golgi
apparatu
tgn
coloc
furin
hat
express
predominantli
plasma
membran
fig
data
strongli
suggest
cleav
ha
tgn
moreov
observ
demonstr
cleavag
ha
monobas
multibas
cleavag
site
perform
compart
differ
proteas
cf
fig
ha
cleavag
hat
demonstr
take
place
cell
surfac
auser
et
al
interestingli
hat
one
hand
capabl
cleav
newli
synthes
probabl
assembl
bud
new
virion
plasma
membran
thu
infecti
viru
contain
cleav
ha
releas
hatexpress
cell
furthermor
hat
cleav
incom
viru
stage
entri
attach
cell
facilit
infect
hatexpress
cell
viru
contain
noncleav
fig
activ
ha
two
differ
step
viru
replic
seem
redund
first
consid
differ
cell
type
airway
epithelium
express
partial
differ
proteas
repertoir
activ
incom
viru
hat
may
enabl
proteolyt
activ
progeni
virus
releas
cell
lack
express
appropri
proteas
fig
concept
support
observ
wsn
viru
activ
upon
entri
mdbk
cell
boycott
et
al
still
unknown
whether
autocatalyt
activ
hat
occur
plasma
membran
alreadi
transit
constitut
secretori
pathway
plasma
membran
fig
therefor
remain
analys
whether
hat
could
cleav
newli
synthes
also
within
cell
addit
ha
cleavag
plasma
membran
mention
solubl
form
hat
describ
shed
solubl
hat
cell
supernat
also
observ
mdckhat
cell
auser
et
al
solubl
form
show
margin
enzymat
activ
fig
right
panel
suffici
support
cleavag
influenza
viru
ha
cell
indic
ha
cleavag
human
airway
epitheli
cell
occur
cellassoci
solubl
proteas
interestingli
enhanc
shed
hat
differenti
human
nasal
epitheli
cell
nec
henc
enhanc
influenza
viru
replic
observ
upon
exposur
ozon
kesic
et
al
thu
enhanc
shed
hat
stress
condit
chronic
airway
diseas
might
play
role
influenza
infect
human
airway
howev
studi
need
prove
hypothesi
recent
studi
demonstr
hat
support
proteolyt
activ
influenza
b
virus
sar
coronaviru
human
metapneumoviru
singl
arginin
vitro
therefor
may
play
role
activ
spread
differ
respiratori
virus
human
airway
shirogan
et
al
matsuyama
et
al
shulla
et
al
auser
et
al
also
known
widespread
tissu
distribut
feldmann
et
al
seidah
et
al
cleavag
ha
indic
amino
acid
sequenc
shown
arrow
proteas
express
differ
human
tissu
list
promin
express
level
highlight
bold
commonli
influenza
viru
ha
activ
either
singl
arginin
trypsinlik
proteas
hat
multibas
motif
ubiquit
furin
howev
number
studi
demonstr
strict
separ
appli
influenza
isol
influenza
virus
possess
uncommon
cleavag
site
motif
may
facilit
activ
addit
proteas
one
best
studi
except
influenza
viru
neurotrop
mice
ha
contain
unusu
ha
cleavag
site
iqyr
instead
iqsr
cf
fig
tyrosin
shown
facilit
effici
cleavag
plasmin
support
proteolyt
activ
viru
spread
tissu
includ
brain
lazarowitz
choppin
goto
kawaoka
sun
et
al
avian
influenza
viru
outbreak
pennsylvania
loss
carbohydr
side
chain
due
singl
point
mutat
shown
respons
appear
high
virul
chicken
influenza
viru
possess
multibas
cleavag
site
motif
kkkr
lowpathogen
isol
contain
oligosaccharid
demonstr
interfer
cleavag
ha
steric
hindranc
kawaoka
et
al
interestingli
upon
serial
passag
nonpathogen
isol
chicken
embryo
cell
pathogen
mutant
emerg
retain
carbohydr
side
chain
instead
possess
increas
number
basic
amino
acid
cleavag
site
ohuchi
et
al
thu
mask
cleavag
site
oligosaccharid
overcom
extens
cleavag
site
multibas
motif
kkkr
howev
cleav
furin
lysin
k
recent
studi
type
ii
transmembran
proteas
wide
express
sever
tissu
tabl
shown
cleav
ha
motif
enabl
system
infect
independ
furin
okumura
et
al
anoth
exampl
unusu
ha
cleavag
recent
describ
influenza
virus
subtyp
circul
worldwid
becom
highli
preval
poultri
mani
countri
virus
associ
repeat
outbreak
sever
ill
poultri
farm
middl
east
occasion
transmit
pig
human
rais
concern
pandem
potenti
contrast
subtyp
virus
vari
remark
amino
acid
sequenc
ha
cleavag
site
virus
america
europ
africa
contain
divers
monobas
ha
cleavag
site
motif
mani
recent
isol
asia
middl
east
possess
dior
tribas
ha
cleavag
site
sequenc
rssr
rsrr
importantli
dior
tribas
cleavag
site
virus
evolv
substitut
insert
basic
amino
acid
case
hpaiv
subtyp
fig
cleav
ubiquit
furin
gohrbandt
et
al
soda
et
al
hat
demonstr
cleav
mono
diand
tribas
cleavag
site
motif
baron
et
al
moreov
ttsp
matriptas
shown
cleav
rssr
rsrr
cleavag
site
baron
et
al
matriptas
express
wide
rang
tissu
high
express
level
kidney
tabl
interestingli
nephrotrop
observ
outbreak
chicken
accord
virus
rssr
rsrr
cleavag
site
abl
undergo
multicycl
replic
primari
chicken
embryo
kidney
cek
cell
due
proteolyt
activ
ha
isol
contain
singl
r
ha
activ
cek
cell
inhibit
matriptas
inhibitor
suggest
matriptas
may
contribut
nephrotrop
virus
chicken
baron
et
al
howev
remain
investig
whether
express
matriptas
wide
rang
tissu
affect
organ
tropism
pathogen
virus
vivo
bacteri
coinfect
contribut
significantli
morbid
mortal
influenza
infect
season
epidem
pandem
outbreak
mcculler
rehg
mcculler
moren
et
al
meterski
et
al
bacteri
infect
occur
concomit
secondari
influenza
infect
influenza
viru
shown
increas
suscept
secondari
bacteri
infect
multipl
factor
exposur
bacteri
attach
site
receptor
due
virusinduc
tissu
damag
remov
sialic
acid
viral
na
decreas
mucociliari
clearanc
bacteria
modul
local
immun
respons
synerg
influenza
viru
bacteria
review
detail
mcculler
mcculler
tashiro
et
al
b
demonstr
bacteri
infect
may
also
forth
benefit
virusbi
produc
proteas
facilit
cleavag
ha
strain
staphylococcu
aureu
aureu
shown
secret
proteas
capabl
cleav
ha
certain
influenza
strain
vitro
fig
interestingli
activ
ha
demonstr
specif
bacteria
viru
strain
thu
exampl
proteas
secret
aureu
wood
abl
cleav
ha
ha
fig
contrast
proteas
produc
aureu
capabl
activ
ha
cleav
ha
sever
influenza
viru
isol
remark
intranas
coinfect
mice
aureu
wood
result
fatal
diseas
extend
lesion
lung
fig
c
left
diagram
infect
either
viru
aureu
wood
alon
caus
signific
symptom
diseas
relev
patholog
alter
lung
fig
low
viru
titr
found
lung
mice
infect
aswin
alon
wherea
hightitr
werepres
inlung
homogen
mice
coinfect
aureu
wood
fig
left
diagram
importantli
infect
viru
lung
homogen
mice
infect
viru
markedli
enhanc
trypsin
treatment
prior
plaqu
titrat
indic
ineffici
ha
cleavag
mice
contrast
infect
progeni
viru
mice
coinfect
aureu
wood
could
increas
treatment
trypsin
suggest
ha
alreadi
effici
cleav
thu
coinfect
influenza
viru
aureu
strain
secret
appropri
hacleav
proteas
may
promot
sever
pneumonia
due
enhanc
activ
spread
viru
accordingli
coinfect
mice
influenza
virus
aureu
strain
produc
proteas
fail
cleav
ha
viru
vitro
lead
signific
symptom
diseas
anim
fig
c
low
viru
titr
present
lung
mice
coinfect
viru
bacteria
infect
viru
alon
infect
progeni
viru
increas
trypsin
treatment
agreement
studi
tashiro
et
al
proteas
secret
aerococcu
viridan
demonstr
cleav
ha
sever
influenza
viru
isol
coinfect
mice
result
sever
pneumonia
fatal
outcom
scheiblauer
et
al
howev
haactiv
proteas
aureu
viridan
identifi
yet
mechan
underli
strainspecif
differ
ha
activ
remain
unknown
addit
haactiv
proteas
h
influenza
pneumonia
strain
describ
far
attempt
isol
haactiv
proteas
bacteria
present
respiratori
tract
pig
lower
digest
tract
waterfowl
fail
callan
et
al
king
et
al
interestingli
indirect
mechan
influenza
viru
activ
upon
coinfect
bacteria
propos
contribut
secondari
bacteri
pneumonia
scheiblauer
et
al
observ
pseudomona
aeruginosa
frequent
complic
patient
cystic
fibrosi
secret
proteas
capabl
cleav
ha
simultan
administr
tashiro
et
al
b
patholog
alter
lung
mice
mice
infect
either
aureu
wood
influenza
viru
coinfect
pathogen
noninfect
mice
use
control
lung
taken
day
pi
tashiro
et
al
mice
indic
surviv
fatal
infect
anim
c
viru
titr
mice
lung
viru
titr
lung
homogen
mice
infect
certain
influenza
virus
aureu
strain
shown
plaqueform
unit
pfu
per
lung
lung
homogen
either
treat
trypsin
remain
untreat
plaqu
titrat
infect
viru
alon
without
trypsin
treatment
coinfect
without
trypsin
treatment
tashiro
et
al
mice
indic
surviv
fatal
infect
respect
proteas
influenza
viru
mice
result
sever
infect
high
viru
titr
lung
mortal
rate
analysi
bronchoalveolar
lavag
bal
fluid
mice
reveal
increas
trypsinlik
proteas
activ
compar
bal
mice
infect
absenc
p
aeruginosa
proteas
increas
proteas
activ
assum
result
inflammatoryinduc
releas
trypsinlik
host
proteas
remain
analys
detail
moreov
gener
plasmin
inact
zymogen
plasminogen
plasminogen
activ
bacteria
staphylokinas
streptokinas
aureu
variou
streptococci
respect
suggest
facilit
enhanc
ha
activ
coinfect
influenza
viru
scheiblauer
et
al
tse
et
al
infect
mice
influenza
strain
activ
plasmin
simultan
treatment
plasminogen
either
staphylokinas
streptokinas
develop
sever
pneumonia
high
viru
titr
lung
scheiblauer
et
al
contribut
certain
bacteria
proteolyt
activ
influenza
virus
human
airway
develop
pneumonia
still
remain
demonstr
howev
bacteri
proteas
might
provid
novel
drug
target
treatment
viralbacteri
coinfect
effort
identif
character
might
support
develop
appropri
inhibitor
outlook
haactiv
proteas
provid
potenti
drug
target
current
avail
measur
control
influenza
human
vaccin
antivir
medic
target
viral
na
protein
treatment
option
becom
limit
due
develop
drugresist
virus
na
inhibitor
furthermor
product
influenza
vaccin
newli
emerg
viru
far
requir
month
highlight
urgent
need
novel
drug
target
haactiv
host
cell
proteas
provid
potenti
drug
target
due
crucial
role
viru
infect
earli
studi
use
broadrang
serin
proteas
inhibitor
aprotinin
bovin
lung
demonstr
influenza
viru
replic
embryon
chicken
egg
mice
markedli
suppress
inhibit
ha
cleavag
zhirnov
et
al
zhirnov
et
al
aprotinin
aerosol
treatment
shown
protect
mice
otherwis
lethal
influenza
infect
significantli
reduc
viru
titr
lesion
lung
moreov
clinic
trial
inhal
aerosol
aprotinin
patient
season
influenza
parainfluenza
markedli
reduc
durat
symptom
without
caus
side
effect
zhirnov
et
al
inhibit
host
factor
haactiv
proteas
novel
approach
influenza
treatment
besid
lack
knowledg
relev
proteas
recent
concern
possibl
side
effect
toxic
limit
develop
drug
target
identif
hat
haactiv
proteas
human
airway
howev
provid
potenti
drug
target
recent
progress
develop
proteas
inhibitor
consider
interestingli
mice
defici
hat
activ
respect
shown
lack
discern
phenotyp
indic
function
redund
compens
physiolog
function
host
proteas
kim
et
al
sale
et
al
knockdown
express
use
antisens
peptideconjug
morpholino
oligom
ppmo
strongli
suppress
influenza
viru
replic
human
airway
epitheli
cell
without
affect
cell
viabil
substrat
analogu
peptid
mimet
inhibitor
hat
contain
moieti
residu
demonstr
effici
suppress
influenza
viru
replic
hatexpress
cell
ottcher
et
al
auser
et
al
sielaff
et
al
moreov
peptid
mimet
inhibitor
shown
drastic
reduc
viru
titr
delay
influenza
viru
propag
h
airway
epitheli
cell
vitro
auser
et
al
remark
combin
proteas
inhibitor
current
na
inhibitor
oseltamivir
carboxyl
highli
synergist
effici
block
influenza
viru
propag
human
airway
epitheli
cell
develop
abovement
proteas
inhibitor
may
lead
novel
drug
consid
influenza
treatmenta
monotherapi
combin
na
inhibitor
mention
specif
inhibitor
furin
recent
develop
demonstr
effici
suppress
viru
replic
hpaiv
subtyp
cell
cultur
inhibit
ha
cleavag
therefor
provid
promis
concept
treatment
hpaiv
infect
human
like
combin
na
inhibitor
exampl
oseltamivir
becker
et
al
lu
w
garten
steinmetz
prepar
therapi
viralbacteri
pneumonia
secondari
bacteri
pneumonia
follow
influenza
consid
antimicrobi
drug
antivir
na
inhibitor
review
detail
mcculler
meterski
et
al
coinfect
studi
anim
model
suggest
best
option
prevent
secondari
bacteri
pneumonia
prevent
influenza
infect
influenza
vaccin
huber
et
al
mcculler
moreov
vaccin
influenza
viru
superinfect
bacteria
consid
reason
limit
avail
vaccin
certain
superinfect
bacteria
differ
strain
interestingli
tashiro
et
al
demonstr
haactiv
proteas
secret
differ
aureu
strain
inhibit
natur
broadrang
proteas
inhibitor
leupeptin
treatment
mice
coinfect
aureu
wood
leupeptin
led
reduc
viru
titr
lung
surviv
anim
wherea
nontreat
mice
develop
fatal
pneumonia
cf
fig
summari
haactiv
proteas
shown
repres
potenti
drug
target
influenza
treatment
combin
appropri
proteas
inhibitor
current
antivir
andor
antimicrobi
drug
provid
novel
promis
approach
consid
treatment
influenza
viralbacteri
pneumonia
proteolyt
activ
influenza
viru
ha
essenti
viru
infect
spread
identif
relev
proteas
human
airway
demonstr
ha
cleavag
occur
membranebound
proteas
take
place
differ
cellular
compart
either
tgn
cell
surfac
addit
ha
activ
occur
differ
time
point
viral
life
cycl
transport
ha
plasma
membran
bud
releas
progeni
viru
late
time
point
upon
attach
entri
new
cell
remark
bacteria
aureu
pneumonia
demonstr
secret
proteas
cleav
ha
directli
produc
protein
augment
activ
relev
host
cell
proteas
therebi
may
facilit
ha
activ
upon
coinfect
thu
influenza
virus
activ
differ
proteas
mechan
human
airway
epithelium
fig
time
cleavag
ha
potent
drug
target
treatment
influenza
infect
due
crucial
role
viru
infect
identif
character
relev
proteas
provid
basi
develop
specif
proteas
inhibitor
novel
influenza
drug
